Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: hypromellose; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; titanium dioxide; purified talc; macrogol 6000; magnesium stearate; hyprolose; croscarmellose sodium - indicated for the treatment of hypertension. indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; purified talc; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; hyprolose; croscarmellose sodium; titanium dioxide; macrogol 6000 - indicated for the treatment of hypertension. indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; purified talc; lactose monohydrate; hypromellose; titanium dioxide; magnesium stearate; hyprolose; macrogol 6000; croscarmellose sodium - indicated for the treatment of hypertension. indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - irbesartan -

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - irbesartan, quantity: 75 mg - tablet, film coated - excipient ingredients: mannitol; crospovidone; povidone; sodium lauryl sulfate; colloidal anhydrous silica; magnesium stearate; purified water; titanium dioxide; hypromellose; macrogol 400 - for the treatment of hypertension. for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (equal to or greater than 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.